Acute Myocardial Infarction, Adverse Event
Conditions
Keywords
Acute myocardial infarction, Major adverse cardiac and cerebrovascular event, Optimized treatment
Brief summary
AMI Survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.
Interventions
AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion
Sponsors
Study design
Eligibility
Inclusion criteria
* AMI survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction and completed the 1-year visit. * Telephone to obtain informed consent from the subjects/family members of the subjects.
Exclusion criteria
* Not available
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of MACCE | 5 years after discharge | the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group | 5 years after discharge | Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group |
| Differences of MACCE between the optimized group and the non-optimized group | 5 years after discharge | Differences of the MACCE between the optimized group and the non-optimized group |
| Differences of the MACCE between OCT-guided group and the coronary angiography -guided group | 5 years after discharge | Differences of the MACCE between OCT-guided group and the coronary angiography -guided group |
| Differences of MACCE between defer PCI group and direct PCI group | 3 and 5 years after discharge | Differences of MACCE between defer PCI group and direct PCI group |
Countries
China